4073 results about "Triazine" patented technology

A triazine compound of the formulawherein Ar1, Ar2, Ar3, and Ar4 are each an aryl, aliphatic, or a mixture of aryl and aliphatic; R1 and R2 are selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, halogen, and cyano; and L is L(n) wherein n is zero or 1, said L being a divalent group.

Provided are select imidazo[1,2-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 2′ position of the nucleoside sugar is substituted with halogen and carbon substituents. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections caused by both wild type and mutant strains of HCV.

A kit for dental adhesive comprising a radical polymerizable monomer having an acid group in the molecule, a photosensitizer and / or a peroxide, a water-soluble organic solvent, an organic sulfinic acid and / or a salt thereof or a barbituric acid and / or a derivative thereof, and water. The kit may further comprises a radical polymerizable monomer which has no acid group and is insoluble or hardly soluble in water, an amine compound, a silane coupling agent and a 1,3,5-triazine-2,4-dithion derivative. By using this kit, the adhesive composition can be applied directly to a dentine without conducting a pretreatment.

A method is disclosed for intermittently mitigating hazardous sulfur compounds, such as hydrogen sulfide, mercaptans and sulfur oxides, from a fluid in the head space of a wellbore. The method comprises contacting the fluid with a foamed aqueous stream comprising an active scavenging agent, such as a triazine, and a stiff foaming agent. The scavenging agent reacts with hazardous sulfur compounds to eliminate the compounds from the fluid stream in the vapor space of the wellbore without withdrawing the hydrocarbon from the wellbore and without releasing hazardous sulfur compounds to the environment.

Disclosed are stabilized aliphatic polyester compositions comprising an aliphatic polyester, a HALS, and a tris-aryl-S-triazine UV absorber that show low embrittlement, haze formation, and discoloration during weathering. Also disclosed are aliphatic polyester compositions comprising aliphatic polyester, a hindered amine light stabilizer, a triazine UV absorber, and a phosphite that exhibit low color prior to weathering but retain good clarity, color, and excellent impact strength after exposure to weathering conditions. The aliphatic polyester compositions may be used prepare shaped articles such as, for example, films, sheets, bottles, tubes, profiles, fibers, and molded articles.

A process for preparing 2-(2,4-dihydroxyphenyl)-4.6-diaryl-s-triazines in three steps starting with cyanuric chloride is described. Step 1 involves the nucleophilic (basic) displacement of one chlorine atom with a phenolic moiety. Step 2 involves a Friedel-Crafts reaction using a Lewis acid catalyst (preferably aluminum chloride) to replace the remaining two chlorine atoms with aryl groups such as xylyl. Finally, step 3 involves replacing the phenolic moiety with resorcinol using either a Lewis acid or protic acid catalyst or combinations thereof. Some additional processes only peripherally related to the three-step process outlined above are also described for the preparation of various s-triazine compounds. The s-triazines prepared are useful as UV absorbers for the stabilization of organic substrates against the adverse effects of actinic light.

Provided are imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

A polymer containing a triazine ring-containing repeating unit structure represented by, for example, formula (23) or (24), which alone can achieve high heat resistance, high transparency, high refraction index, high solubility and low volume shrinkage, without adding a metal oxide.

The present invention realizes a display device or input device having excellent ultraviolet protection property for the touch panel, display element or the like, while retaining optical characteristics, even when a small amount of or no optical film is used. The pressure-sensitive adhesive sheet of the present invention has a total light transmittance of 85% or more, a light transmittance at a wavelength of 380 nm of 5% or less, and a haze of 3% or less. The pressure-sensitive adhesive sheet preferably includes a pressure-sensitive adhesive layer containing an acrylic polymer and a triazine-based ultraviolet absorber.

In a light emitting apparatus comprising a light emitting device, a fluorescent substance capable of absorbing at least a portion of light emitted by the light emitting device and emitting light having a different wavelength, and a color converting member which contains the fluorescent substance and directly coat the light emitting device, the color converting member contains at least an epoxy resin derived from triazine and a mixing ratio of the epoxy resin derived from triazine to the acid anhydride curing agent in the color converting member is from 100:80 to 100:240.

The invention relates generally to pyrimidines and triazines ultraviolet light absorbers containing a phenolic aromatic group(s) and a non-phenolic aromatic group(s) and the use thereof to protect against degradation by environmental forces, inclusive of ultraviolet light, actinic radiation, oxidation, moisture, atmospheric pollutants, and combinations thereof. The new class of pyrimidines and triazines includes two (one) non-phenolic aromatic groups with hydrocarbyl groups that are ortho to each other and one (two) resorcinol or substituted resorcinol group attached to a triazine or pyrimidine ring. The pyrimidines and triazines may be included in a polymeric structure. A method for stabilizing a material by incorporating the novel pyrimidines and triazines is also disclosed.

The invention provides a preparation method of triazine structure containing benzoxazine intermediate, which sequentially includes: (1) performing synthetic reaction of aldehyde compound and amine compound at a molar ratio of at least 1:1 which includes adding aldehyde compound and solvent of at least one of clean water, methanol, ethanol, isopropanol, and ethyl acetate into a reactor at the room temperature under the normal pressure to obtain mixed solution with aldehyde mass concentration of no greater than 95%, adding amine compound while stirring, and reacting at 0-100 DEG C under the normal pressure for at least 15 minutes to obtain the reactant liquor; (2) pouring into the cleaning solution, stirring and cleaning, and filtering to collect solid substance, or directly filtering the reactant liquor to collect the solid substance; and (3) drying the solid substance obtained in step (2) at 30-100 DEG C.

The use of a dialdehyde (e.g. glyoxal) and a nitrogen-containing scavenger (e.g. a triazine) when injected separately in media containing hydrogen sulfide (H2S) and / or mercaptans to scavenge H2S and / or mercaptans therefrom gives a synergistically better reaction rate and overall scavenging efficiency, i.e. capacity, over the use of the dialdehyde or the nitrogen-containing scavenger used alone, but in the same total amount of the dialdehyde and nitrogen-containing scavenger. The media may include an aqueous phase, a gas phase, a hydrocarbon phase and mixtures of a gas and / or hydrocarbon phase with an aqueous phase.

The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.

In the proposed condensation product based on amino-s-triazines with at least two amino groups, formaldehyde and sulphite, the molar ratio of amino-s-triazine, formaldehyde and sulphite is 1:2.5-6.0:1.51-2.0 and the formiate content is less than 0.3 wt %. The condensation product is obtained by a) heating amino-s-triazine, formaldehyde and a sulphite in the molar ratio 1:2.5-6.0:1.51-2.0 in an aqueous solution at a temperature of 60-90° C. and a pH level of between 9.0 and 13.0 until the sulphite can no longer be detected; b) continuing the condensation at a pH level of between 3.0 and 6.5 and a temperature of 60-80° C. until the condensation product has a viscosity of 5-50 mm / s at 80° C.; and c) adjusting the pH level of the condensation product to 7.5-12.0 or carrying out thermal secondary treatment at a pH level of >10.0 and a temperature of 60-100° C. The product can be used as an additive for inorganic binders such as cement.

The present invention relates to preventives or remedies for Alzheimer's disease, or to amyloid protein fibril-formation inhibitors, which include as an active ingredient a compound of general formula (I) below or a pharmacologically permitted salt thereof; and also to nitrogen-containing heteroaryl derivatives having specific substituents, or pharmacologically permitted salts thereof, which are valuable as preventives or remedies for Alzheimer's disease, or as amyloid protein fibril-formation inhibitors: (where, R1 and R2 are H or alkyl; Z1 and Z2 are H, alkyl, alkoxy, haloalkyl or halogeno; Z3 is alkoxy, SH, alkylthio, NH2, mono- or di-alkylamino, OH or halogeno; Z4 and Z5 are H or halogeno; and A is 4,6-pyrimidine-1,3-diyl, 1,3,5-triazine-2,6-diyl, etc).

The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-sero-tonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamaza-pine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.

The present invention provides novel 1,3,5-triazinane-2,4,6-trione derivatives, such as compounds of any one of Formulae (I) and (II), and salts thereof, and methods of preparing the compounds. Also provided are compositions including a compound of the invention and an agent (e.g., an siRNA, mRNA, or plasmid DNA). The present invention also provides methods and kits using the compositions for delivering an agent to a subject (e.g., to the liver, spleen, or lung of the subject) or cell and for treating and / or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, liver diseases, and lung diseases.

The invention relates to novel therapeutic agents and diagnostic probes. The invention also relates to phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor triazine-, pyrimidine- and pyridine-based compoundŝ Formula (I), their stereoisomers, geometric isomers, tautomers, solvates, metabolites, N-oxide derivatives, pharmaceutically acceptable salts, and prodrugs thereof compositions of the new compounds; either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, for treating disorders mediated by lipid kinases. •Methods of using compounds of Formula (I) for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. (Formula I)

Ultraviolet light absorbing polymer film, coating, or molded article UV filter elements are described which comprise a polymer phase having molecularly dispersed therein a) a first ultraviolet absorbing dibenzoylmethane compound of formula (I) where R1 through R5 are each independently hydrogen, halogen, nitro, or hydroyxl, or further substituted or unsubstituted alkyl, alkenyl, aryl, alkoxy, acyloxy, ester, carboxyl, alkyl thio, aryl thio, alkyl amine, aryl amine, alkyl nitrile, aryl nitrile, arylsulfonyl, or 5-6 member heterocylce ring groups, and b) a second ultraviolet light absorbing compound which absorbs ultraviolet light at a wavelength for which the first compound is deficient at absorbing. In particular embodiments, the second ultraviolet light absorbing compound may comprise a hydroxyphenyl-s-triazine, hydroxyphenylbenzotriazole, formamidine, benzoxazinone, or benzophenone compound. In a specific embodiment of the invention, the above UV absorbing compounds are employed in cellulose acetate film for the fabrication of a protective film for polarizers for use in display applications.

The invention discloses an oxa-phosphaphenanthrene flame retardant compound containing the sym-triazine structure and a preparation method thereof. The method is characterized in that an intermediate is synthesized from 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide(DOPO) and p-hydroxybenzaldehyde as raw material by the solution method, and then reacts with cyanuric chloride in the presence of phase transfer catalyst to obtain a 2,4,6-tri(4-(10-methenyl hydroxy-9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide)phenoxy)-1,3,5-triazine product. The compound is white crystal, and has a melting point of 166 to 169 DEG C, good thermal stability and high flame retardation efficiency, and can be adopted as a reactive flame retardant for the flame retardation of thermosetting resins such as epoxy resin, polyurethane and the like, and also as an additive flame retardant for the flame retardation of engineering plastics such as ABS, nylon and the like.

Containers for smokeless tobacco products and other consumer and food products are provided. The containers include a layer of fibrous material, wherein the layer of fibrous material includes a moisture barrier layer imbedded within the layer of fibrous material or carried on an outer surface of the layer of fibrous material as a coating, the moisture barrier layer incorporating at least one of: (i) a triazine-containing compound; (ii) a nano-cellulose material; (iii) a nanoclay material; (iv) a polymer composition comprising one or more of a salt of one or more of myristic, palmitic and stearic acid, polyvinyl alcohol, and a C9-C18 fatty acid complex of a metal ion having an oxidation state of at least three; and (v) an inorganic oxide material.

The invention provides an imine coupled covalent organic framework material and a preparation method and application thereof and belongs to the technical field of porous materials. The structural formula of the imine coupled covalent organic framework material is shown in the description, and the material can be prepared by triazinyl aromatic polyamine A and alkoxy substituted aromatic aldehyde B through simple Schiff base condensation reaction. Under visible light excitation condition, the prepared imine coupled covalent organic framework material can catalyze multiple types of organic reactions, specifically for example reaction for photocatalysis of N-aryl tetrahydroisoquinoline and nucleophilic reagent. The prepared covalent organic framework material has very good chemical stability and heat stability, high specific surface area and high crystallinity, has strong visible light absorption properties, can serve as an excellent heterogeneous photocatalyst and has good industrial application prospect.

Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein.

A composition comprising: (a) polyethylene; (b) as a scorch inhibitor, [1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione]; (c) a thioester; (d) a hindered amine stabilizer; and (e) an organic peroxide.

A flame-retardant resin composition comprises (A) abase resin; (B) a flame retardant comprising (B1) at least one aromatic resin selected from a pblyphenylene oxide-series resin and a polyphenylene sulfide-series resin, (B2) a phosphoric ester, and (B3) a nitrogen-containing cyclic compound; and (C) a styrenic resin having a melt flow rate of not more than 8 g / 10 minutes. The base resin may be a polyester-series resin. The styrenic resin (C) may be a styrenic resin having a melt flow rate of 0.1 g / 10 minutes to not more than 5 g / 10 minutes. The phosphoric ester (B2) may be a condensed phosphoric ester, and the nitrogen-containing cyclic compound (B3) may be a polyphosphate of an amino group-containing triazine compound, a polyphosphoric acid amide, or others. The present invention provides a flame-retardant resin composition which has been flame-retarded without using a halogen-containing flame retardant.